Clinical trials
Completed Body Weight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
440 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 17 |
| 2007 | 9 |
| 2008 | 16 |
| 2009 | 27 |
| 2010 | 23 |
| 2011 | 23 |
| 2012 | 34 |
| 2013 | 23 |
| 2014 | 27 |
| 2015 | 22 |
| 2016 | 28 |
| 2017 | 20 |
| 2018 | 16 |
| 2019 | 26 |
| 2020 | 22 |
| 2021 | 29 |
| 2022 | 23 |
| 2023 | 15 |
| 2024 | 13 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 440 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pennington Biomedical Research Center | 9 |
| University of California, San Diego | 9 |
| University of Pittsburgh | 8 |
| Oregon Health and Science University | 7 |
| University of North Carolina, Chapel Hill | 6 |
| University of Pennsylvania | 6 |
| Yale University | 6 |
| Isfahan University of Medical Sciences | 5 |
| Columbia University | 4 |
| Leo Wang | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Body Weight | 440 |
| Obesity | 178 |
| Overweight | 87 |
| Weight Loss | 51 |
| Body Weight Changes | 28 |
| Diabetes Mellitus, Type 2 | 27 |
| Insulin Resistance | 21 |
| Metabolic Syndrome | 19 |
| Nutrition Disorders | 18 |
| Diabetes Mellitus | 17 |
Trials
Showing 51 to 75 of 440. Each trial links to its page on Pharma Observatory.
340 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.